Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

17 January 2002

Effect of tissue injury on D-Dimer levels: a prospective study in trauma patients.

Samuel Cemaj, Samir Johna, Richard Catalano

Med Sci Monit 2002; 8(1): CR5-8 :: ID: 420948

Abstract

BACKGROUND: D-Dimer measurement has been used as a simple, non-invasivetest to rule out thromboembolic phenomena in patients at risk for deep venous thrombosis (DVT) and /or pulmonary embolism (PE). Elevated D-Dimer level caused by tissue injury is believed to show a trendfor gradual decrease to normal within the first three days after trauma. MATERIAL/METHODS: To study theeffect of tissue injury on D-Dimer levels, we conducted a prospective measurement of D-Dimer levels inseverely traumatized, high-risk patients for DVT or PE, starting within 24 hours after admission untildisposition of the patient or to a total of 14 days of hospitalization. Patients were observed clinicallyfor development of thromboembolic phenomena, and were subjected to weekly surveillance using duplex scanof the lower extremities. Additional testing was done if requested by the attending trauma surgeon. RESULTS:A total of 21 patients were enrolled in the study. There were 17 males, and 4 females. Patients had amean age of (42) with a range of (17-79), and a mean ISS score of (20) with a range of (4-50). Sevenpatients completed 3-9 days of testing. Fourteen patients had more than 10 days of testing. Nine patientscompleted 14 days of testing. In all patients, tissue injury resulted in increased levels of D-Dimerabove a threshold (500 ng/ml), below which DVT or PE can be ruled out. The increased levels failed tonormalize even when testing was continued for 14 days. CONCLUSIONS: In our study, the increased D-Dimerlevels induced by tissue injury failed to show a trend of gradual return to normal within three daysafter trauma, as currently believed. This, in our opinion, may eliminate our ability to use D-Dimer testingto rule out DVT or PE in a subset of severely traumatized patients in the early post trauma period.

Keywords: Adolescent, Fibrin Fibrinogen Degradation Products, Pulmonary Embolism, Research Support, Non-U.S. Gov, Time Factors, Venous Thrombosis, Wounds and Injuries

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750